Tags: nanomedicine

Description

Nanomedicine is the medical application of nanotechnology. Nanomedicine ranges from the medical applications of nanomaterials, to nanoelectronic biosensors, and even possible future applications of molecular nanotechnology. Current problems for nanomedicine involve understanding the issues related to toxicity and environmental impact of nanoscale materials. More information on Nanomedicine can be found here.

All Categories (21-40 of 181)

  1. Arozia Moazzam

    http://nanohub.org/members/68134

  2. Tejasvi SVRV Parupudi

    Graduate student working on Biomedical Microdevices on low cost portable platforms for implantable and surface use. Use of biomimetic principles and energy efficient processes.

    http://nanohub.org/members/67949

  3. Sneha Choudhury

    http://nanohub.org/members/66483

  4. Application of Dynamic Light Scattering in the Physicochemical Characterization of Natural and Engineered Nanoparticles

    20 Apr 2012 | | Contributor(s):: Trisha Eustaquio

    This presentation will highlight the use of dynamic light scattering (DLS), which measures the hydrodynamic size of nanoparticles in suspension, in characterizing specific examples of engineered and natural nanoparticles. In terms of engineered nanoparticles, the role of nanoparticle size in...

  5. The Importance of Zeta Potential for Drug/Gene Delivery in Nanomedicine

    11 Apr 2012 | | Contributor(s):: James Leary

    Keynote Address

  6. Finding a Needle in a Haystack: Nanobarcoding for Single Nanoparticle Detection in in vitro and ex vivo Nanomedical Biodistribution Studies

    14 Feb 2012 | | Contributor(s):: Trisha Eustaquio

    Determination of the fate of administered nanoparticles in a biological system, or nanoparticle biodistribution, is critical in evaluating a nanoparticle formulation for nanomedical purposes. Unlike their small-molecule drug antecedents, nanoparticles pose unique challenges in the design of...

  7. emiley krystine herbert

    '''----== ^,,Hello My name's Emiley Krystine. I'm fifteen years old and i'm a freshmen in high school. I am very interested in science. My favorite subjects are Nanotechnology, Astrophysics,...

    http://nanohub.org/members/61913

  8. Illinois Nano EP Seminar Series Spring 2011: Interfacing Engineering, Biology, and Medicine at the Micro and Nano Scale

    13 Dec 2011 | | Contributor(s):: Rashid Bashir

    In this talk, we will present an overviewof our work in Silicon-Based BioMEMS and Bionanotechnology and discuss the state of the art and thefuture challenges and opportunities. We will review a range of projects in our group focused towardsdeveloping rapid detection of biological entities and...

  9. KIST/PU Advances in detection systems for biology: Classifying signals from fluorescence and scatter

    08 Dec 2011 | | Contributor(s):: J. Paul Robinson

    Biology-driven advances in photonic detection systems have been dramatic in the last several years. Three specific aspects are of particular interest: molecular detection, cellular detection, and whole-organ or small-animal imaging. Each area of study requires specific probes, detectors, and...

  10. KIST/PU Nanostructured Heparin Derivatives as an Angiogenesis Inhibitor

    07 Dec 2011 | | Contributor(s):: Youngro Byun

    Although low molecular weight heparin (LMWH) has been known to regulate angiogenesis, tumor growth and metastasis, the administration of heparin for treating cancer is limited in clinical application due to its unsatisfactory therapeutic effects and a strong anticoagulant activity, which induces...

  11. KIST/PU 6th Annual Symposium: High Impact Research to Society

    07 Dec 2011 |

    In 2006, the South Korean Ministry of Science and Technology selected the KIST and Purdue team project from 20 international research proposals submitted to examine how to learn more about the molecular makeup of diseases.

  12. KIST/PU The Professor’s Challenge: To commercialize or not, that is the question?

    06 Dec 2011 | | Contributor(s):: J. Paul Robinson

    Outline:Outline the Professors DilemmaShow what the normal criteria for research project direction isDiscuss the Corporate perspectiveDiscuss an example of failed innovationDemonstrate how time can impact an innovative ideaConclusions

  13. KIST/PU Designing a Research Program Around Unmet Clinical Needs

    06 Dec 2011 | | Contributor(s):: Alyssa Panitch

  14. KIST/PU Theragnosis – A New Paradigm of Personalized Medicine

    06 Dec 2011 | | Contributor(s):: Ick Chan Kwon

    Companion Diagnosis, based on pharmacogenomics, has been recognized as one of most important key representatives of personalized medicine. However, Companion Diagnosis does not provide any clues in developing new ways of therapeutics but it only provides a best choice of drugs based on given...

  15. saranya balachandran

    http://nanohub.org/members/61116

  16. Illinois BioNanotechnology Seminar Series Fall 2011: Deconvolving Stiffness in MEMS Pedestal Cell Mass Measurements

    05 Dec 2011 | | Contributor(s):: Elise Corbin

    The complex relationships between a cell's behavior and the physical properties of both itself and its environment have long been of interest. Specifically, the understanding the mechanisms through which a cell's physical properties influence cell growth, cell differentiation, cell cycle...

  17. Illinois BioNanotechnology Seminar Series Fall 2011: Directed Blood Vessel Growth Using an Angiogenic Microfiber/Microparticle Composite Patch

    05 Dec 2011 | | Contributor(s):: Ross J DeVolder

    Therapeutic angiogenesis has emerged as a promising strategy to treat various acute and chronic vascular diseases, and to enhance tissue repair and regeneration. Common revascularization therapies include the administration of angiogenic factors, such as vascular endothelial growth factor...

  18. Illinois BioNanotechnology Seminar Series Fall 2011: Precisely Size Controlled Drug-silica Nanoconjugate for Cancer Therapy

    05 Dec 2011 | | Contributor(s):: Li Tang

    Drug delivery nanomedicine, exemplified by micelles and nanoparticles roughly in the size range of 1-200 nm, have attracted much interest in the past 2-3 decades as alternative modalities for cancer treatment. The size of these drug delivery vehicles has been strongly correlated with their in...

  19. BME 695L Special Lecture 4: Atomic Force Microscopy (AFM) for Nanomedical Systems (cells and nanoparticles)

    02 Dec 2011 | | Contributor(s):: Helen McNally

    Guest lecturer: Helen McNally

  20. BME 695L Special Lecture 3: In vivo Model Systems to Study Nanomedical Approaches to Cancer Detection and Intervention

    02 Dec 2011 | | Contributor(s):: Deborah W Knapp

    Guest lecturer: Deborah Knapp.